Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...

PepMLM generates binders to challenging therapeutic targets across cancer and neurological disease using protein sequence and ...

The two designed compounds, dubbed NG1 and DN1, effectively treated N. gonorrhoeae and S. aureus respectively in preclinical models.

Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the CDC7 inhibitor died in a Phase I trial.

Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.

Peptidoglycan hydrolases killed living bacteria, opening the door for further research into the interplay between archaea and bacteria.

Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

Absci and Almirall have expanded their 21-month-old AI-based collaboration to develop and commercialize therapeutics for chronic skin diseases.

Antimicrobial resistance studies often focus on individual protein variants, neglecting broader protein family dynamics. Dihydrofolate reductase (DHFR), a key antibiotic target, has been extensively ...

The basal ganglia in rats uses separate codes for learned movements and “natural” behaviors, offering insights into human ...

Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.